Clinical Trial Update: FAP-targeted PET/NIR in Lung Malignant Tumors

View source ↗

Summary

An ongoing clinical trial is evaluating a fibroblast activation protein (FAP)-targeted PET/near-infrared imaging agent in non-small cell lung cancer, with recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Peking University People's Hospital | Conditions: Non-Small Cell Lung Cancer, PET/CT | Status: RECRUITING